This federal contract award with ID SPE2DB20D3505|SPE2DB25FT3A9 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.32 firm fixed-price delivery order is for the supply of 4,566,181,522 units of the pharmaceutical product Hydralazine 25 mg tablet. The contract has an ultimate completion date of October 23, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/27/25, 1:27 PM